SCM
BRLI

Saba Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Saba Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-53,502
Closed -$1.62M – 218
2014
Q2 		$1.62M Sell
53,502
-16,498
-24% -$455K 0.08% 136
2014
Q1 		$1.94M Buy
+70,000
New +$1.83M 0.11% 133

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Saba Capital Management's BRLI Position: Q3 2014 in Review

Saba Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2014, closing a stake of 53,502 shares — an estimated $1.62M sold.

Saba Capital Management first reported a position in BRLI in Q1 2014 and held it in 2 quarters. The position peaked at $1.94M in Q1 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q3 2014.

  • Saba Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2014 after selling out during the quarter.
  • Saba Capital Management sold 53,502 BIO-REFERENCE LABS INC-NEW- shares in Q3 2014, an estimated $1.62M.
  • Saba Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 2 quarters.
  • Saba Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.94M in Q1 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2014.

Based on Saba Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.